Pulmonary toxicity of antineoplastic drugs

J. K V Willson

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Drug-induced pulmonary disease is an infrequent, but clinically significant, toxic manifestation of antineoplastic drug therapy. Pulmonary toxicity has been associated primarily with bleomycin therapy but also has been described with busulfan, cyclophosphamide, methotrexate, and the nitrosoureas. Cytotoxic drug-induced pulmonary disease is characterized by an insidious and nonspecific presentation. The common pathologic process of a fibrosing alveolitis follows a variety of toxic mechanisms associated with the chemotherapeutic agents. The importance of close clinical monitoring is emphasized by the necessity for early withdrawal of the drug in order to halt or reverse potentially lethal pulmonary disease. At the same time, the nonspecific nature of the lung disease and the multitude of potential insults to the lung in a cancer patient make an early aggressive evaluation mandatory. A lung biopsy is almost always indicated.

Original languageEnglish (US)
Pages (from-to)2003-2008
Number of pages6
JournalCancer Treatment Reports
Volume62
Issue number12
StatePublished - 1978

Fingerprint

Antineoplastic Agents
Lung Diseases
Lung
Poisons
Pharmaceutical Preparations
Busulfan
Pulmonary Fibrosis
Bleomycin
Pathologic Processes
Methotrexate
Cyclophosphamide
Biopsy
Drug Therapy
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Willson, J. K. V. (1978). Pulmonary toxicity of antineoplastic drugs. Cancer Treatment Reports, 62(12), 2003-2008.

Pulmonary toxicity of antineoplastic drugs. / Willson, J. K V.

In: Cancer Treatment Reports, Vol. 62, No. 12, 1978, p. 2003-2008.

Research output: Contribution to journalArticle

Willson, JKV 1978, 'Pulmonary toxicity of antineoplastic drugs', Cancer Treatment Reports, vol. 62, no. 12, pp. 2003-2008.
Willson, J. K V. / Pulmonary toxicity of antineoplastic drugs. In: Cancer Treatment Reports. 1978 ; Vol. 62, No. 12. pp. 2003-2008.
@article{98a65733ce6e49f88cea50dda9eb93dd,
title = "Pulmonary toxicity of antineoplastic drugs",
abstract = "Drug-induced pulmonary disease is an infrequent, but clinically significant, toxic manifestation of antineoplastic drug therapy. Pulmonary toxicity has been associated primarily with bleomycin therapy but also has been described with busulfan, cyclophosphamide, methotrexate, and the nitrosoureas. Cytotoxic drug-induced pulmonary disease is characterized by an insidious and nonspecific presentation. The common pathologic process of a fibrosing alveolitis follows a variety of toxic mechanisms associated with the chemotherapeutic agents. The importance of close clinical monitoring is emphasized by the necessity for early withdrawal of the drug in order to halt or reverse potentially lethal pulmonary disease. At the same time, the nonspecific nature of the lung disease and the multitude of potential insults to the lung in a cancer patient make an early aggressive evaluation mandatory. A lung biopsy is almost always indicated.",
author = "Willson, {J. K V}",
year = "1978",
language = "English (US)",
volume = "62",
pages = "2003--2008",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Pulmonary toxicity of antineoplastic drugs

AU - Willson, J. K V

PY - 1978

Y1 - 1978

N2 - Drug-induced pulmonary disease is an infrequent, but clinically significant, toxic manifestation of antineoplastic drug therapy. Pulmonary toxicity has been associated primarily with bleomycin therapy but also has been described with busulfan, cyclophosphamide, methotrexate, and the nitrosoureas. Cytotoxic drug-induced pulmonary disease is characterized by an insidious and nonspecific presentation. The common pathologic process of a fibrosing alveolitis follows a variety of toxic mechanisms associated with the chemotherapeutic agents. The importance of close clinical monitoring is emphasized by the necessity for early withdrawal of the drug in order to halt or reverse potentially lethal pulmonary disease. At the same time, the nonspecific nature of the lung disease and the multitude of potential insults to the lung in a cancer patient make an early aggressive evaluation mandatory. A lung biopsy is almost always indicated.

AB - Drug-induced pulmonary disease is an infrequent, but clinically significant, toxic manifestation of antineoplastic drug therapy. Pulmonary toxicity has been associated primarily with bleomycin therapy but also has been described with busulfan, cyclophosphamide, methotrexate, and the nitrosoureas. Cytotoxic drug-induced pulmonary disease is characterized by an insidious and nonspecific presentation. The common pathologic process of a fibrosing alveolitis follows a variety of toxic mechanisms associated with the chemotherapeutic agents. The importance of close clinical monitoring is emphasized by the necessity for early withdrawal of the drug in order to halt or reverse potentially lethal pulmonary disease. At the same time, the nonspecific nature of the lung disease and the multitude of potential insults to the lung in a cancer patient make an early aggressive evaluation mandatory. A lung biopsy is almost always indicated.

UR - http://www.scopus.com/inward/record.url?scp=0018222906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018222906&partnerID=8YFLogxK

M3 - Article

C2 - 87268

AN - SCOPUS:0018222906

VL - 62

SP - 2003

EP - 2008

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 12

ER -